Matt Hewitt

Stock Analyst at Craig-Hallum

(2.67)
# 1,995
Out of 4,884 analysts
40
Total ratings
51.35%
Success rate
3.66%
Average return

Stocks Rated by Matt Hewitt

Simulations Plus
Jun 13, 2025
Maintains: Buy
Price Target: $45$36
Current: $17.75
Upside: +102.82%
Champions Oncology
Mar 12, 2025
Maintains: Buy
Price Target: $8$12
Current: $7.68
Upside: +56.25%
Clover Health Investments
Dec 17, 2024
Initiates: Buy
Price Target: $6
Current: $2.56
Upside: +134.38%
BioLife Solutions
Nov 13, 2024
Maintains: Buy
Price Target: $30$32
Current: $22.84
Upside: +40.11%
Omnicell
Oct 31, 2024
Maintains: Buy
Price Target: $45$64
Current: $29.84
Upside: +114.48%
Inotiv
May 16, 2024
Maintains: Buy
Price Target: $25$10
Current: $2.09
Upside: +378.47%
Schrödinger
May 2, 2024
Maintains: Buy
Price Target: $35$30
Current: $21.12
Upside: +42.05%
MaxCyte
Nov 29, 2023
Initiates: Buy
Price Target: $7
Current: $2.24
Upside: +213.20%
Repligen
Aug 3, 2023
Maintains: Buy
Price Target: $207$200
Current: $127.47
Upside: +56.90%
OmniAb
Apr 13, 2023
Initiates: Buy
Price Target: $10
Current: $1.93
Upside: +418.13%
Maintains: Hold
Price Target: $67$30
Current: $8.29
Upside: +261.88%
Initiates: Buy
Price Target: $400
Current: $0.99
Upside: +40,304.04%